Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapsed/Refractory Autoimmune Diseases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Very early researchLooking for participantsNCT07448298
What this trial is testing

A Clinical Study of AFN50 in the Treatment of Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Beijing Boren Hospital 18
Early research (Phase 1)WithdrawnNCT03605238
What this trial is testing

Treatment of Relapsed and/or Refractory AQP4-IgG Seropositive NMOSD by Tandem CAR T Cells Targeting CD19 and CD20

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Chinese PLA General Hospital
Not applicableNot Yet RecruitingNCT07605637
What this trial is testing

Early Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of STR-P005

Who this might be right for
Relapsed/Refractory Autoimmune Diseases
Beijing GoBroad Hospital 18
Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Very early researchLooking for participantsNCT06680388
What this trial is testing

CD19 CAR-T in the Treatment of Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Autoimmune Diseases
Institute of Hematology & Blood Diseases Hospital, China 15
Not applicableLooking for participantsNCT05925023
What this trial is testing

Sirolimus in the Treatment of Refractory/Relapsed wAIHA

Who this might be right for
Warm Autoimmune Hemolytic Anemia
Peking Union Medical College Hospital 22
Early research (Phase 1)Active Not RecruitingNCT06220201
What this trial is testing

Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)

Who this might be right for
Multiple SclerosisMyasthenia Gravis
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company 120
Early research (Phase 1)UnknownNCT06212154
What this trial is testing

CAR-T for Autoimmune Hemolytic Anemia Patients Who Have Failed Three or More Lines of Therapy

Who this might be right for
Autoimmune Hemolytic AnemiaCD19 CAR-T Cell Infusion
Institute of Hematology & Blood Diseases Hospital, China 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07324889
What this trial is testing

An Open-label, Single-arm, Prospective, Multicenter, Phase I/II Clinical Study on the Safety and Efficacy of CD19/BCMA CAR-T Cell Therapy for Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia

Who this might be right for
Relapsed/Refractory Warm Antibody Autoimmune Hemolytic Anemia
Yihao Wang 24
Testing effectiveness (Phase 2)UnknownNCT03460808
What this trial is testing

The Combination of Atorvastatin, Acetylcysteine and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Peking University People's Hospital 200
Not applicableLooking for participantsNCT07143617
What this trial is testing

Exploratory Clinical Study on the Safety of STR-P004

Who this might be right for
Autoimmune Diseases
Beijing GoBroad Hospital 39
Testing effectiveness (Phase 2)Looking for participantsNCT06991114
What this trial is testing

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Who this might be right for
Refractory Rheumatoid Arthritis (RA)Idiopathic Inflammatory Myopathies (IIMs)Systemic Sclerosis (SSc)+6 more
Artiva Biotherapeutics, Inc. 90
Early research (Phase 1)Looking for participantsNCT07236801
What this trial is testing

Exploratory Clinical Study on YTS109 Cell Therapy for Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic SclerosisSjogren's Syndrome (SS)+3 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 18
Early research (Phase 1)Looking for participantsNCT06978647
What this trial is testing

A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Inflammatory Myopathy+5 more
China Immunotech (Beijing) Biotechnology Co., Ltd. 12
Very early researchNot Yet RecruitingNCT06420154
What this trial is testing

The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
First Affiliated Hospital of Wenzhou Medical University 9
Very early researchLooking for participantsNCT04561557
What this trial is testing

Safety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System

Who this might be right for
Autoimmune DiseasesAutoimmune Diseases of the Nervous SystemNeuromyelitis Optica Spectrum Disorder+7 more
Tongji Hospital 36
Very early researchNot Yet RecruitingNCT07265206
What this trial is testing

HY001N in the Treatment of Relapsed or Refractory Neurological Autoimmune Diseases

Who this might be right for
Neurological Autoimmune Diseases
Juventas Cell Therapy Ltd. 15
Testing effectiveness (Phase 2)Ended earlyNCT05168475
What this trial is testing

Biologics in Refractory Vasculitis: A Trial of Biologic Therapy for Refractory Primary Non-ANCA Associated Vasculitis

Who this might be right for
Giant Cell ArteritisTakayasu ArteritisCogan Syndrome+6 more
Cambridge University Hospitals NHS Foundation Trust 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT07388277
What this trial is testing

CC-97540 in Patients With Antineutrophil Cytoplasmic Antibody-associated Vasculitis

Who this might be right for
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
Marcela V. Maus, M.D.,Ph.D. 12
Early research (Phase 1)Not Yet RecruitingNCT07790575
What this trial is testing

Autoimmune Cytopenia Elimination by Chimeric Antigen Receptor T-cell Therapy

Who this might be right for
Cytopenia
Saurabh Dahiya 16
Next Page